Search
Grace Therapeutics, Inc
GRCEAdd to Watchlist
2.270USD
0.0000.00%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
36.37MMarket Cap
LossP/E TTM
Grace Therapeutics, Inc's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Grace Therapeutics, Inc is 7.40, ranking 230 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -7.19, which is -95.99% below the recent high of -0.29 and -129.02% above the recent low of -16.47.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.